$44.30
0.01140.03%
At close: Sep 25, 5:00 PM EST
Franklin Genomic Advancements ETF (HELX) Stock Price, Quote, News & History
HELXBATS
Franklin Genomic Advancements ETF (HELX) Stock Price, Quote, News & History | Benzinga
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
33.20M
Fund Score
Loading...
Key Statistics
Open
$44.18
High
$44.30
52 Wk High
$44.28
AUM
33.20M
Dividend
$0.14
Ex-Div Date
Dec 30, 2025
Volume
858
Market Cap
$49.64B
Mgmt Fee
0.5%
P/E Ratio
30.02
Prev. Close
$44.28
Low
$44.18
52 Wk Low
$29.80
Shares Out
300.00K
Yield
0.32%
Div. Freq
-
Avg. Volume Daily
888.00
Beta
0.98
Avg. Expense Ratio
0.50%
P/B Ratio
6.18
Recent Franklin Genomic Advancements ETF News
FAQ
Q
How do I buy Franklin Genomic Advancements ETF (HELX) stock?
A
You can purchase shares of Franklin Genomic Advancements ETF (BATS:HELX) through any online brokerage.
Q
Who are Franklin Genomic Advancements ETF (HELX) competitors?
A
There are no as such competitors for Franklin Genomic Advancements ETF.
Q
What is the forecast, or price target, for Franklin Genomic Advancements ETF (HELX) stock?
A
There is no analysis for Franklin Genomic Advancements ETF to provide a consensus price target.
Q
What is the current price for Franklin Genomic Advancements ETF (HELX)?
A
The stock price for Franklin Genomic Advancements ETF (BATS: HELX) is $ last updated .
Q
Does Franklin Genomic Advancements ETF (HELX) pay a dividend?
A
There are no upcoming dividends for Franklin Genomic Advancements ETF.
Q
When is Franklin Genomic Advancements ETF (BATS:HELX) reporting earnings?
A
Franklin Genomic Advancements ETF does not have any upcoming earnings scheduled.
Q
Is Franklin Genomic Advancements ETF (HELX) going to split?
A
There is no upcoming split for Franklin Genomic Advancements ETF.
Key Statistics
Open
$44.18
High
$44.30
52 Wk High
$44.28
AUM
33.20M
Dividend
$0.14
Ex-Div Date
Dec 30, 2025
Volume
858
Market Cap
$49.64B
Mgmt Fee
0.5%
P/E Ratio
30.02
Prev. Close
$44.28
Low
$44.18
52 Wk Low
$29.80
Shares Out
300.00K
Yield
0.32%
Div. Freq
-
Avg. Volume Daily
888.00
Beta
0.98
Avg. Expense Ratio
0.50%
P/B Ratio
6.18
About
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Mid Cap Growth |
| Fund Inception | Feb 25, 2020 |
| Managers | Matthew J. Moberg |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Investment Policy
The Fund invests in equity securities inside and outside of the United States, including developing or emerging markets.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| KRYS | Krystal Biotech Inc | 5.75% |
| NTRA | Natera Inc | 8.81% |
| GH | Guardant Health Inc | 9.29% |
| ADPT | Adaptive Biotechnologi... | 4.38% |
| BBIO | Bridgebio Pharma Inc | 3.32% |
| LGND | Ligand Pharmaceuticals... | 4.41% |
| VRTX | Nvaesrtex Pharmaceutic... | 2.78% |
| TWST | Twist Bioscience Corp. | 3.75% |
| TVTX | Travere Therapeutics I... | 3.26% |
| MEDP | Medpace Holdings Inc | 2.71% |
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved